Investors in AcelRx Pharmaceuticals Inc (ACRX - Get Report) saw new options begin trading this week, for the November 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACRX options chain for the new November 17th contracts and identified one put and one call contract of particular interest.The put contract at the $2.50 strike price has a current bid of 20 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $2.50, but will also collect the premium, putting the cost basis of the shares at $2.30 (before broker commissions). To an investor already interested in purchasing shares of ACRX, that could represent an attractive alternative to paying $3.27/share today. Because the $2.50 strike represents an approximate 24% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 78%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 8.00% return on the cash commitment, or 50.31% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for AcelRx Pharmaceuticals Inc, and highlighting in green where the $2.50 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $5.00 strike price has a current bid of 20 cents. If an investor was to purchase shares of ACRX stock at the current price level of $3.27/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $5.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 59.02% if the stock gets called away at the November 17th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if ACRX shares really soar, which is why looking at the trailing twelve month trading history for AcelRx Pharmaceuticals Inc, as well as studying the business fundamentals becomes important. Below is a chart showing ACRX's trailing twelve month trading history, with the $5.00 strike highlighted in red: Considering the fact that the $5.00 strike represents an approximate 53% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 80%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 6.12% boost of extra return to the investor, or 38.46% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example is 135%, while the implied volatility in the call contract example is 147%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $3.27) to be 66%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Boeing Shares Slip After Report Raises Safety Questions Linked to 787 Dreamliner
Boeing shares were indicated lower Monday as the company reacted to a New York Times report focused on production and oversight at the planemaker's South Carolina factory that produces its long-haul 787 Dreamliner.
Oil Prices, Tesla, Boeing, Whirlpool and 420 - 5 Things You Must Know
U.S. stock futures point lower as investors come off the three-day Easter break confronted with a sharp spike in oil prices; Whirlpool and Halliburton report earnings; Tesla holds its autonomous investor day on Monday.
Dow Futures Drift Lower as Earnings Wave Approaches: Oil Tests Six-Month Highs
Global stocks drifted lower Monday, as major markets in Europe and Asia remained closed for Easter celebrations, while oil prices tested six months highs amid reports that the U.S. will end waivers for the purchase of Iranian crude next week.
Jim Cramer Unveils His 5 Rules for Trading Stocks During Earnings Season
Jim tells members of his Action Alerts PLUS club for investors what to look for when earnings reports come in.